We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$9.15M
Cap. Flow
-$18.1M
Cap. Flow %
-12.5%
Top 10 Hldgs %
26.79%
Holding
704
New
1
Increased
73
Reduced
49
Closed
564

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$269K
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$197K
3
MO icon
Altria Group
MO
+$144K
4
MPT
Medical Properties Trust
MPT
+$127K
5
XOM icon
ExxonMobil
XOM
+$117K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$582K
2
MPC icon
Marathon Petroleum
MPC
+$200K
3
AER icon
AerCap
AER
+$196K
4
XPO icon
XPO
XPO
+$195K
5
CPB icon
Campbell Soup
CPB
+$186K

Sector Composition

Rank Sector Weight
1 Technology 16.31%
2 Healthcare 10.05%
3 Consumer Staples 8.95%
4 Communication Services 7.78%
5 Industrials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NLY icon
426
Annaly Capital Management
NLY
$17.4B
– –
-1,400
Closed -$49K
NOBL icon
427
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
– –
-888
Closed -$32K
NOC icon
428
Northrop Grumman
NOC
$81.2B
– –
-75
Closed -$28K
NOK icon
429
Nokia
NOK
$52.3B
– –
-4,942
Closed -$25K
NOV icon
430
NOV
NOV
$7B
– –
-975
Closed -$21K
NTR icon
431
Nutrien
NTR
$30.7B
– –
-1,418
Closed -$71K
NVG icon
432
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.7B
– –
-705
Closed -$12K
NVMI
433
Nova
NVMI
$12.5B
– –
-995
Closed -$32K
NVO
434
Novo Nordisk
NVO
$209B
– –
-5,264
Closed -$136K
NVS icon
435
Novartis
NVS
$297B
– –
-513
Closed -$45K
NVT icon
436
nVent Electric
NVT
$26.7B
– –
-2,110
Closed -$47K
NWL icon
437
Newell Brands
NWL
$2.56B
– –
-3,508
Closed -$66K
NZF icon
438
Nuveen Municipal Credit Income Fund
NZF
$2.45B
– –
-1,000
Closed -$16K
O icon
439
Realty Income
O
$59.1B
– –
-295
Closed -$22K
OBE
440
Obsidian Energy
OBE
$662M
– –
-214
Closed –
OEC icon
441
Orion
OEC
$409M
– –
-900
Closed -$15K
OLED icon
442
Universal Display
OLED
$4.19B
– –
-192
Closed -$32K
OMER icon
443
Omeros
OMER
$959M
– –
-305
Closed -$5K
OPI
444
DELISTED
Office Properties Income Trust
OPI
– –
-1,590
Closed -$49K
OTEX icon
445
Open Text
OTEX
$6.04B
– –
-685
Closed -$28K
OXY icon
446
Occidental Petroleum
OXY
$55.9B
– –
-722
Closed -$32K
PAA icon
447
Plains All American Pipeline
PAA
$16.1B
– –
-650
Closed -$13K
PAHC icon
448
Phibro Animal Health
PAHC
$1.39B
– –
-769
Closed -$16K
PAYX icon
449
Paychex
PAYX
$42.7B
– –
-440
Closed -$36K
PBW icon
450
Invesco WilderHill Clean Energy ETF
PBW
$461M
– –
-102
Closed -$3K
16 17
18
19 20

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Truvestments Capital held 704 positions worth $144M, down 6% from $154M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Truvestments Capital withdrew a net $18.1M in Q4 2019, closing 564 positions and reducing 49 holdings. Its most notable exit was Celgene Corp, an estimated $582K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Truvestments Capital opened a new position in Vanguard FTSE Developed Markets ETF worth $204K.

  • Truvestments Capital's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 4,627 shares worth $204K.
  • Truvestments Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $269K increase.
  • Truvestments Capital's biggest Q4 2019 reduction was Apple, cutting an estimated $151K.
  • Truvestments Capital fully exited Celgene Corp in Q4 2019, selling an estimated $582K.
  • Truvestments Capital's ten largest holdings make up 27% of its $144M portfolio in Q4 2019.
  • Truvestments Capital opened 1 new position and closed 564 in Q4 2019.
  • Truvestments Capital's portfolio value fell 6% quarter-over-quarter to $144M.

Based on Truvestments Capital's 13F filing for Q4 2019, filed 29 Jan 2020.